CRISPR Therapeutics
Leading gene-editing company developing CRISPR/Cas9-based therapeutics, including Casgevy (exagamglogene autotemcel), the first FDA-approved CRISPR gene therapy for sickle cell disease and beta-thalassemia.
Website
https://www.crisprtx.comLocation
Zug, Switzerland & Boston, Massachusetts, USA
Founded
2013
Investors
1
Categories
therapeutics, biotech, gene-editing, crispr, cell-therapy, genetic-diseases
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Vertex Pharmaceuticals | Boston, Massachusetts, USA | cvc | series-aseries-b+2 | 1 |
